Thanks for posting this Natalie!

The FDA usually follows the recommendation of the advisory committee, but not always. There are a lot of safety concerns with this drug, but the advisory committee voted to approve because with monitoring, they feel the benefits will outweigh the risks shown in study information. The FDA may require a trial for an 0.25 mg dose to be run to see if a lower dose is less risky, if they approve the 0.5 mg dose. It's thought that they may require a program similar to "Touch" for approval. Hopefully no weird stuff pops up after approval!!

It looks like orals may actually be here!